With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Chambers UK, 2018
Chambers Europe-wide, 2018
Legal 500, 2018
Chambers Asia-Pacific, 2018
Chambers Global- wide, 2018
The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).
Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...
Earlier this year (17 July 2019) in Takeda UK Limited v F. Hoffmann-La Roche AG Mr Justice Colin Birss of the Patents Court of the English High Court of Justice handed down a judgment holding that Roche’s European ...
International law firm Bird & Bird joins 26 organisations in a European Commission funded project that draws on big data to improve the health and wellbeing of European citizens. The four-year project aims to build a ...
International law firm Bird & Bird today announces the merger of its Baseline consulting arm with Valeocon Management Consulting, creating one of the largest management consultancy firms linked to an international law ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
There are no forthcoming events for this area. Please click on the button below to view past events.
The French Health Data hub becomes a reality. Read more here: https://t.co/xXRPTVn4ar
RT @twobirds: Due to their commercial value toxicity study reports are covered by a general presumption of confidentiality and their disclo…
The English Patents Court examines the law on enablement in the context of lack of novelty based on both prior publ… https://t.co/a38JxAPOxc